Eisai Trial Site 1

Koto-ku, Tokyo

0 studies enrolling now · 1 studies all time

What they study most

Thyroid Cancer

Studies at this site

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC) — Completed